MLS-101
Mineralys Therapeutics
[]
mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc $mlys 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice